Epstein Secrets

4,000.000 100.80 (4,030.00) 3/16 3/21 Purchase MERRILL LYNCH & CO MEDIUM TERM NOTES 6 7/8% APR 25 2018 DTD 04/25/2008 @ 110.463 CREDIT SUISSE FIRST BOSTON LLC (ID: 59018Y-N6-4) 3.000.000 110.50 (3,313.89) 3/16 3/21 Purchase OEP RESOURCES INC 5 3/8% OCT 01 2022 DTD 03/01/2012 0 99.00 GOLDMAN SACHS &

9380-AC-4) (3,000.000) 89.50 2,685.00 (3,090.00) (405.00) S 5/1 5/4 Sale High Cost ARCH COAL INC 7 114% OCT 01 2020 DTD 08/09/2010 0 89.25 CREDIT SUISSE FIRST BOSTON LLC (3.000.000) 89.30 2,677.50 (3,090.00) (412.50) S (ID: 039380-AC-4) J.P.Morgan SB1062192-F1 Page 21 of 25 1795 EFTA01663667

IELSEN FINANCE LLCM() 111.25 10,000.00 11,125.00 11,040.00 85.00 775.00 5.69% 7 3/4% OCT 15 2018 292.77 DID 04/15/2011 654090-AY-8 BB-182 DAVITA INC 106.00 10,000.00 10,600.00 10,200.00 400.00 637.50 5.29% 6 3/8% NOV 01 2018 212.50 DID 10/20/2010 23918K-AL-2 B 182 J. P. Morgan Page 10

100.75 DEUTSCHE BANK ALEX BROWN (ID: 125581-GL-6) MERRILL LYNCH & CO MEDIUM TERM NOTES 6 7/8% APR 25 2018 DTD 04/25/2008 @ 110.463 CREDIT SUISSE FIRST BOSTON LLC (ID: 59018Y-N6-4) QEP RESOURCES INC 5 3/8% OCT 01 2022 DTD EFTA01573557 03/01/2012 @ 99.00 GOLDMAN SACHS & CO. (ID: 74733V-AB-6) QEP RESOURCES

S SR NOTES 8 1/8% OCT 01 2018 DTD 10/01/2009 35906A-AB-4 BB /BA2 NIELSEN FINANCE LLC/CO 7 3/4% OCT 15 2018 DTD 04/15/2011 65409Q-AY-8 BB- /B2 DAVITA INC 6 3/8% NOV 01 2018 DTD 10/20/2010 23918K-AL-2 B /B2 CSC HOLDINGS LLC 8 5/8% FEB 15 2019 DTD 02/12/2009 126307-AC-1 BB /BA3 HCA INC 8 1/2% APR

ion Method Description Settled Sales/Maturities/Redemptions Sale High Cost Sale High Cost SUPERVALU INC 8% MAY 01 2016 DTD 05/07/2009 @ 100.00 CREDIT SUISSE FIRST BOSTON LLC (ID: 868536-AT-0) SUPERVALU INC 8% MAY 01 2016 DTD 05/07/2009 @ 99.875 FIRST UNION CAPITAL MARKETS (ID: 868536-AT-0) (1,000.000) 99.875 998.75

ER KING CORP 9 7/8% OCT 15 2018 DTD 10/19/2010 121207-AA-2 B /B3 NIELSEN FINANCE LLC/CO 7 3/4% OCT 15 2018 DTD 04/15/2011 65409Q-AY-8 BB- /B2 DAVITA INC 6 3/8% NOV 01 2018 DTD 10/20/2010 23918K-AL-2 NR /B2 TENET HEALTHCARE CORP 6.25% NOV 01 2018 DTD 11/21/2011 88033G-BP-4 B+ /B1 110.88 5,000.00

Proceeds Tax Cost Gain/Loss Settled Seles/MatudtlestRedemptIons 1/30 2/4 Sale High Cost SUPERVALU INC 8% MAY 01 2016 DTD 05/07/2009 @ 100.00 CREDIT SUISSE FIRST BOSTON LLC (ID: 868536-AT-0) (2,000.000) 100.00 2,000.00 (2,075.00) (75.00) L' 1/30 2/4 Sale High Cost SUPERVALU INC 8% MAY 01 2016 DID 05/07/2009 0

31/13 Price Ouantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annua) Income Yield Original Cost Accrued Interest US Fixed Income DAVITA INC 107.25 10,000.00 10,725.00 10,200.00 525.00 637.50 4.91 % 6 3/8% NOV 01 2018 159.37 DTD 10/20/2010 23918K.AL-2 NR /62 TENET HEALTHCARE CO